Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Liabilities (2019 - 2020)

Ascendis Pharma A (ASND) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $3.8 million as the latest value for Q4 2020.

  • Quarterly Other Non-Current Liabilities rose 275.11% to $3.8 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2020, up 275.11% year-over-year, with the annual reading at $3.8 million for FY2020, 275.11% up from the prior year.
  • Other Non-Current Liabilities hit $3.8 million in Q4 2020 for Ascendis Pharma A, up from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.8 million in Q4 2020 to a low of $1.0 million in Q4 2019.